5% STAKE4883.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Modalis Therapeutics to 7.74%

Stake history

5%10%15%20%15.95%PriorPrior: 15.95% · prior ratio stated in S100U2AC11.95%Jul 19Jul 19: 11.95% · S100U2AC10.84%Jul 31Jul 31: 10.84% · S100U4O97.74%Aug 16Aug 16: 7.74% · S100U8RP
5%10%15%20%15.95%PriorPrior: 15.95% · prior ratio stated in S100U2AC11.95%Jul 19Jul 19: 11.95% · S100U2AC10.84%Jul 31Jul 31: 10.84% · S100U4O97.74%Aug 16Aug 16: 7.74% · S100U8RP

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-16 15:15 JST concerning Modalis Therapeutics Corporation. Reported holding ratio: 7.74%, previous report: 10.84%.

Open the price chart on TradingView.

Source: EDINET S100U8RP ↗ · PDL1.0 · Not investment advice